Dan Lin
Impact in
- Health Informatics top 10%
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
- Oncology 6
- Cancer Cells and Metastasis 5
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Jingyuan Wan (4 shared papers)Hongzhong Li (4 shared papers)Hongyuan Li (4 shared papers)Rong Jiang (3 shared papers)Xiang Zhang (3 shared papers)Bingjie Li (5 shared papers)Jingsi Dong (5 shared papers)Ge Kuang (3 shared papers)
- Journals
- Oncology Reports (3 papers)Frontiers in Pharmacology (2 papers)Chromatographia (2 papers)Frontiers in Oncology (2 papers)Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Dan Lin
15 papers receiving 608 citations
Peers
Comparison fields: 5 of 90
- Health Informatics 18
- Biochemistry 72
- Applied Microbiology and Biotechnology 14
- Cancer Research 96
- Pharmacology 101
Countries citing papers authored by Dan Lin
This map shows the geographic impact of Dan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lin more than expected).
Fields of papers citing papers by Dan Lin
This network shows the impact of papers produced by Dan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lin. The network helps show where Dan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 157 | |
| 2 | 2016 | 103 | |
| 3 | 2019 | 83 | |
| 4 | 2018 | 69 | |
| 5 | 2017 | 43 | |
| 6 | 2019 | 36 | |
| 7 | 2019 | 28 | |
| 8 | 2020 | 27 | |
| 9 | 2015 | 21 | |
| 10 | 2019 | 14 | |
| 11 | 2015 | 11 | |
| 12 | 2010 | 10 | |
| 13 | 2010 | 8 | |
| 14 | 2015 | 6 | |
| 15 | 2009 | 1 | |
| 16 | 2013 | 0 | |
| 17 | 2022 | 0 |
About Dan Lin
Dan Lin is a scholar working on Oncology, Pharmacology, Pulmonary and Respiratory Medicine, Cancer Research and Analytical Chemistry, having authored 17 papers that have together received 617 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Cancer Genomics and Diagnostics (2 papers), Artificial Intelligence in Healthcare and Education (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Pesticide Residue Analysis and Safety (1 paper). The work is most often cited by research in Health Informatics (18 citations), Biochemistry (72 citations), Applied Microbiology and Biotechnology (14 citations), Cancer Research (96 citations) and Pharmacology (101 citations). Dan Lin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jingyuan Wan, Hongzhong Li, Hongyuan Li, Rong Jiang, Xiang Zhang, Bingjie Li, Jingsi Dong, Ge Kuang, Xia Gong and Depei Huang. Their work appears in journals such as Oncology Reports, Frontiers in Pharmacology, Chromatographia, Frontiers in Oncology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.